{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:19:19Z","timestamp":1758709159832},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2002,7,3]],"date-time":"2002-07-03T00:00:00Z","timestamp":1025654400000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2002,6]]},"abstract":"<jats:p> <jats:bold>BACKGROUND<\/jats:bold> : Routine HCV NAT of blood donors to detect persons in the preseroconversion phase of acute infection was introduced in Canada in October 1999. The source of virus exposure was investigated in the first, and to date only, blood donor found to be HCV NAT positive, anti\u2010HCV negative in Canada. He was a regular donor with none of the commonly reported risk factors for HCV infection.<\/jats:p><jats:p> <jats:bold>STUDY DESIGN AND METHODS<\/jats:bold> : Epidemiologic follow\u2010up revealed that the blood donor had received antibiotics at an outpatient IV clinic 5 weeks before donation. IV solution bags and tubing for individual patients were stored in the clinic, and then the same equipment was used each time the patient returned for the next dose of antibiotics until it was replaced after every 72\u2010hour period. Among eight other patients whose clinic visitation times overlapped was a man with chronic HCV infection. Genomic sequencing of HCV isolates from the blood donor, the patient with chronic hepatitis C, and local controls was carried out to study possible nosocomial infection.<\/jats:p><jats:p> <jats:bold>RESULTS<\/jats:bold> : Genomic sequencing showed a high degree of relatedness in the hypervariable region of HCV isolates from the blood donor and putative source patient as compared with controls. Detailed molecular analysis of quasispecies of the HCV isolates further indicated that viruses from the two individuals were genetically very close to each other.<\/jats:p><jats:p> <jats:bold>CONCLUSION<\/jats:bold> : The introduction of routine screening of blood donors by HCV NAT was directly responsible for the early detection and investigation of an unusual case of HCV infection involving a regular donor. Genomic sequencing studies provided firm evidence of patient\u2010to\u2010patient transmission of HCV in an IV clinic. The report clearly demonstrates the value of molecular fingerprinting in tracking nosocomial HCV infections.<\/jats:p>","DOI":"10.1046\/j.1537-2995.2002.00112.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T22:49:48Z","timestamp":1047509388000},"page":"759-765","source":"Crossref","is-referenced-by-count":11,"title":["Acute nosocomial HCV infection detected by NAT of a regular blood\u2003donor"],"prefix":"10.1111","volume":"42","author":[{"given":"Bryce","family":"Larke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2010Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Scalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean\u2003K.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesia\u2003R.","family":"Boychuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,7,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40101165.x"},{"issue":"2","key":"e_1_2_6_3_2","first-page":"3","article-title":"Risk factors for the transmission of hepatitis C.","volume":"24","author":"Zeuzem S","year":"1996","journal-title":"J Hepatol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2000.7930138.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/501879"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2001.00008.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1128\/JCM.38.8.2807-2813.2000","article-title":"Comparison and application of a novel genotyping method, semiautomated primer\u2010specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed\u2010genotype infections.","volume":"38","author":"Hu Y\u2010W","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/jvi.69.2.773-778.1995","article-title":"Sequence evolution of the hypervariable region in the putative region E2\/NS1 of hepatitis C virus is correlated with specific humoral immune responses.","volume":"69","author":"Van Doorn L\u2010J","year":"1995","journal-title":"J Virol"},{"key":"e_1_2_6_9_2","unstructured":"Kleinman SH Stramer SL Mimms L et al. Comparison of preliminary observed yield of HCV and HIV minipool (MP) nucleic acid testing (NAT) with predictions from the incidence\/window period (inc\/wp) model (abstract).Transfusion2000;40(Suppl.):4S; additional data presented at 53rd Annual Meeting of the American Association of Blood Banks Washington DC November 6 2000."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40111422.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40101192.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41030333.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40101198.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41020304.x"},{"key":"e_1_2_6_15_2","unstructured":"Stramer SL. NAT: experience in the USA. Abstracts of the international symposium on advances in transfusion safety\u20102001. Langen Germany: June 7\u20108 2001;p. 31."},{"key":"e_1_2_6_16_2","first-page":"2S","article-title":"Characteristics of blood donors identified as antibody negative\/NAT reactive (abstract).","volume":"40","author":"Caglioti S","year":"2000","journal-title":"Transfusion"},{"key":"e_1_2_6_17_2","first-page":"3S","article-title":"Identification of recent risk factors among blood donors confirmed to be HCV NAT reactive, anti\u2010HCV non\u2010reactive (abstract).","volume":"40","author":"Orton SL","year":"2000","journal-title":"Transfusion"},{"key":"e_1_2_6_18_2","first-page":"13","article-title":"[Recent infections with hepatitis C virus in blood donors and their risk factors.]","volume":"4","author":"Courouc\u00e9 A\u2010M","year":"1998","journal-title":"Bull Epid\u00e9miol Hebd"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250335"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-2-199901190-00007"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890430417"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890440311"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90518-9"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707243370404"},{"key":"e_1_2_6_25_2","first-page":"25","article-title":"Trans\u2010 mission nosocomiale du VHC document\u00e9e lors de l'investigation d'une \u00e9pid\u00e9mie hospitali\u00e8re.","volume":"7","author":"Desenclos JC","year":"1998","journal-title":"Bull Epid\u00e9miol Hebd"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012213432505"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2002.00112.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2002.00112.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T19:09:56Z","timestamp":1697224196000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2002.00112.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["10.1046\/j.1537-2995.2002.00112.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2002.00112.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}